Calls for change as access to cell and gene therapies in the Netherlands falls short
A Gilead executive highlights limited investment in innovation against the need to speed up access to ATMPs.
Cell & Gene Therapy
Imunon’s Phase III-stage IL-12 gene therapy alters tumour microenvironment in ovarian cancer
Sartorius to invest $3m for minority share in biotech start-up Nanotein
JCR Pharma and Alexion partner on JUST-AAV gene therapy platform
Inborn errors of metabolism elicit unique challenges for therapy development
Broader population could benefit from Novartis spinal muscular atrophy treatment
Cartesian shares updated Phase IIb Descartes-08 data and announces Phase III trial plans
FDA shares additional draft guidance on CGTs
